Analyst Reco. Novo Nordisk A/S London S.E.

Equities

Real-time Estimate Cboe Europe Other stock markets 02:45:40 01/07/2024 pm IST			5-day change	1st Jan Change
999.8 ^DKK	-1.46%		+1.29%	+43.12%

28/06	India plans incentives for diabetes, obesity drug makers in 2026, government official says	RE
28/06	NOVO NORDISK : UBS gives a Neutral rating	ZD

NOVO NORDISK : UBS gives a Neutral rating	28/06	ZD
NOVO NORDISK : JP Morgan gives a Buy rating	27/06	ZD
NOVO NORDISK : Goldman Sachs reiterates its Buy rating	27/06	ZD
AlphaValue/Baader Europe Downgrades Novo Nordisk to Add from Buy, Raises PT	26/06	MT
NOVO NORDISK : Deutsche Bank remains its Buy rating	25/06	ZD
NOVO NORDISK : Jefferies reiterates its Sell rating	24/06	ZD
NOVO NORDISK : Gets a Buy rating from JP Morgan	24/06	ZD
India's Biocon seeks partner to test generic Wegovy, Ozempic in China	20/06	RE
NOVO NORDISK : Deutsche Bank remains its Buy rating	20/06	ZD
NOVO NORDISK : Deutsche Bank reiterates its Buy rating	14/06	ZD
Sector Update: Health Care	11/06	MT
Senate Committee to Vote June 18 to Subpoena Novo Nordisk President Doug Langa	11/06	MT
Argus Research Raises Novo Nordisk Price Target to $160 From $125, Maintains Buy Rating	10/06	MT
NOVO NORDISK : Buy rating by Goldman Sachs	30/05	ZD
NOVO NORDISK : Deutsche Bank reaffirms its Buy rating	28/05	ZD
NOVO NORDISK : JP Morgan reiterates its Buy rating	24/05	ZD
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell; Hims & Hers Health to Advance, AMC Entertainment to Decline	21/05	MT
NOVO NORDISK : UBS sticks Neutral	15/05	ZD
NOVO NORDISK : JP Morgan reaffirms its Buy rating	14/05	ZD
NOVO NORDISK : UBS reaffirms its Neutral rating	14/05	ZD